Neuroimaging in Neuro-Oncology
Tóm tắt
Từ khóa
Tài liệu tham khảo
Burger, 1982, The brain: tumors, 223
Burger, 1985, Glioblastoma multiforme and anaplastic astrocytoma: pathologic criteria and prognostic implications, Cancer, 56, 1106, 10.1002/1097-0142(19850901)56:5<1106::AID-CNCR2820560525>3.0.CO;2-2
Kleihues, 2000, World Health Organization classification of tumors, Cancer, 88, 2887, 10.1002/1097-0142(20000615)88:12<2887::AID-CNCR32>3.0.CO;2-F
Kleihues, 2000, Phenotype vs genotype in the evolution of astrocytic brain tumors, Toxicol Pathol, 28, 164, 10.1177/019262330002800121
Ricci, 1999, Imaging of adult brain tumors, Neuroimaging Clin N Am, 9, 651
Felix, 1985, Brain tumors: MR imaging with gadolinium-DTPA, Radiology, 156, 681, 10.1148/radiology.156.3.4040643
Kates, 1996, Fluid-attenuated inversion recovery (FLAIR): clinical prospectus of current and future applications, Top Magn Reson Imaging, 8, 389, 10.1097/00002142-199612000-00005
Ercan, 2004, Diagnostic value of contrast-enhanced fluid-attenuated inversion recovery MR imaging of intracranial metastases, AJNR Am J Neuroradiol, 25, 761
Singer, 1998, Subarachnoid space disease: diagnosis with fluid-attenuated inversion-recovery MR imaging and comparison with gadolinium-enhanced spin-echo MR imaging–blinded reader study, Radiology, 208, 417, 10.1148/radiology.208.2.9680570
Maher, 2001, Malignant glioma: genetics and biology of a grave matter, Genes Dev, 15, 1311, 10.1101/gad.891601
Castillo, 2000, Diffusion-weighted imaging in the evaluation of intracranial lesions, Semin Ultrasound CT MR, 21, 405, 10.1016/S0887-2171(00)90033-7
Schaefer, 2000, Diffusion-weighted MR imaging of the brain, Radiology, 217, 331, 10.1148/radiology.217.2.r00nv24331
Holodny, 2002, Diffusion imaging in brain tumors, Neuroimaging Clin N Am, 12, 107, 10.1016/S1052-5149(03)00072-8
Akai, 2005, Diffusion tensor tractography of gliomatosis cerebri: fiber tracking through the tumor, J Comput Assist Tomogr, 29, 127, 10.1097/01.rct.0000148453.29579.51
Chen, 2007, Diffusion tensor imaging of the brain in patients with Alzheimer's disease and cerebrovascular lesions, J Zhejiang Univ Sci B, 8, 242, 10.1631/jzus.2007.B0242
Mukherjee, 2008, Diffusion tensor MR imaging and fiber tractography: theoretic underpinnings, AJNR Am J Neuroradiol, 29, 632, 10.3174/ajnr.A1051
Nimsky, 2005, Visualization of the pyramidal tract in glioma surgery by integrating diffusion tensor imaging in functional neuronavigation, Zentralbl Neurochir, 66, 133, 10.1055/s-2005-836606
Smith, 2005, Serial diffusion-weighted magnetic resonance imaging in cases of glioma: distinguishing tumor recurrence from postresection injury, J Neurosurg, 103, 428, 10.3171/jns.2005.103.3.0428
Ito, 2002, Diffusion tensor brain imaging and tractography, Neuroimaging Clin N Am, 12, 1, 10.1016/S1052-5149(03)00067-4
Rosen, 1990, Perfusion imaging with NMR contrast agents, Magn Res Med, 14, 249, 10.1002/mrm.1910140211
Weisskoff, 1993, Functional MR imaging of capillary hemodynamics, 473
Weisskoff, 1992, Noninvasive determination of regional cerebral blood flow in rats using dynamic imaging with Gd(DTPA), Magn Reson Med, 25, 211, 10.1002/mrm.1910250122
Aronen, 1994, Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings, Radiology, 191, 41, 10.1148/radiology.191.1.8134596
Knopp, 1999, Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging, Radiology, 211, 791, 10.1148/radiology.211.3.r99jn46791
Sugahara, 1998, Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas, AJR Am J Roentgenol, 171, 1479, 10.2214/ajr.171.6.9843274
Sugahara, 1999, Perfusion-sensitive MRI of cerebral lymphomas: a preliminary report, J Comput Assist Tomogr, 23, 232, 10.1097/00004728-199903000-00011
Cha, 2001, Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions, AJNR Am J Neuroradiol, 22, 1109
Stewart, 1987, Quantitative study of microvessel ultrastructure in human peritumoral brain tissue: evidence for a blood–brain barrier defect, J Neurosurg, 67, 697, 10.3171/jns.1987.67.5.0697
Uematsu, 2000, Vascular permeability: quantitative measurement with double-echo dynamic MR imaging: theory and clinical application, Radiology, 214, 912, 10.1148/radiology.214.3.r00mr15912
Yang, 2003, Dynamic contrast-enhanced perfusion MR imaging measurements of endothelial permeability: differentiation between atypical and typical meningiomas, AJNR Am J Neuroradiol, 24, 1554
Provenzale, 2002, Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging, AJR Am J Roentgenol, 178, 711, 10.2214/ajr.178.3.1780711
Roberts, 2000, Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade, AJNR Am J Neuroradiol, 21, 891
Roberts, 2002, Quantitative estimation of microvascular permeability in human brain tumors: correlation of dynamic Gd-DTPA-enhanced MR imaging with histopathologic grading, Acad Radiol, 9, S151, 10.1016/S1076-6332(03)80425-7
Tofts, 1991, Measurement of the blood–brain barrier permeability and leakage space using dynamic MR imaging: 1, Magn Reson Med, 17, 357, 10.1002/mrm.1910170208
Johnson, 2004, Measuring blood volume and vascular transfer constant from dynamic, T2*-weighted contrast-enhanced MRI, Magn Reson Med, 51, 961, 10.1002/mrm.20049
Burger, 1980, Histologic factors of prognostic significance in the glioblastoma multiforme, Cancer, 46, 1179, 10.1002/1097-0142(19800901)46:5<1179::AID-CNCR2820460517>3.0.CO;2-0
Batchelor, 2007, AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients, Cancer Cell, 11, 83, 10.1016/j.ccr.2006.11.021
Kelly, 1987, Stereotactic histologic correlations of computed tomography and magnetic resonance imaging defined abnormalities in patients with glial neoplasms, Mayo Clin Proc, 62, 450, 10.1016/S0025-6196(12)65470-6
Law, 2006, Comparing perfusion metrics obtained from a single compartment versus pharmacokinetic modeling methods using dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade, AJNR Am J Neuroradiol, 27, 1975
Law, 2008, Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging, Radiology, 247, 490, 10.1148/radiol.2472070898
Valk, 1991, Radiation injury of the brain, AJNR Am J Neuroradiol, 12, 45
Ricci, 1998, Differentiating recurrent tumor from radiation necrosis: time for re- evaluation of positron emission tomography?, AJNR Am J Neuroradiol, 19, 407
Law, 2002, High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging, Radiology, 222, 715, 10.1148/radiol.2223010558
Burtscher, 2000, Proton MR spectroscopy and preoperative diagnostic accuracy: an evaluation of intracranial mass lesions characterized by stereotactic biopsy findings, AJNR Am J Neuroradiol, 21, 84
Li, 2002, Analysis of the spatial characteristics of metabolic abnormalities in newly diagnosed glioma patients, J Magn Reson Imaging, 16, 229, 10.1002/jmri.10147
Al-Okaili, 2006, Advanced MR imaging techniques in the diagnosis of intraaxial brain tumors in adults, Radiographics, 26, S173, 10.1148/rg.26si065513
